29 Nov 2010 07:30
29 November 2010
CATHAY INTERNATIONAL HOLDINGS LIMITED
Completion of the minority investment in
Zhejiang Starry Pharmaceutical Co., Ltd. ('Starry')
Cathay International Holdings Ltd. (LSE: CTI.L) (the 'Company'), a company investing primarily in the growing pharmaceutical and healthcare sectors in the People's Republic of China ('PRC'), refers to the Company's announcement dated 16 November 2010 relating to the proposed minority investment in Starry both by Lansen Pharmaceutical Holdings Limited (HKE: 503.HK) ('Lansen'), the Company's subsidiary listed on the main board of the Hong Kong Exchange, and by the Company.
The Company announces today that the relevant government approval in the PRC has been obtained and both Lansen's purchase of a 20% equity interest and the Company's purchase of a 1.5% equity interest in Starry were completed on 26 November 2010.
Enquiries
Cathay International Holdings Limited | + 852 2828 9289 |
Jinyi Lee / Eric Siu | |
Brunswick | +44 (0)20 7404 5959 |
Jon Coles | |